1. Home
  2. BCPC

as 11-26-2025 3:34pm EST

$
-
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Industrials

Major Chemicals

Nasdaq

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Founded: 1967 Country:
United States
United States
Employees: N/A City: MONTVALE
Market Cap: 5.0B IPO Year: N/A
Target Price: $190.00 AVG Volume (30 days): 171.6K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
0.56%
Dividend Payout Frequency: Annual
EPS: 4.57 EPS Growth: 22.48
52 Week Low/High: $139.17 - $183.60 Next Earning Date: 10-21-2025
Revenue: $1,013,548,000 Revenue Growth: 7.55%
Revenue Growth (this year): 10.31% Revenue Growth (next year): 5.89%

BCPC Daily Stock ML Predictions

Stock Insider Trading Activity of Balchem Corporation (BCPC)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Reid Martin Luther BCPC SVP Chief Supply Chain Officer Nov 11 '25 Sell $154.44 1,200 $185,328.00 7,391

Share on Social Networks: